TNF Pharmaceuticals Inc. (TNFA) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    TNF Pharmaceuticals Inc.

    NASDAQ: TNFA · Real-Time Price · USD
    3.51
    -0.20 (-5.39%)
    At close: Sep 23, 2025, 3:59 PM
    3.50
    -0.28%
    After-hours: Sep 23, 2025, 07:56 PM EDT

    TNF Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 n/a n/a n/a n/a
    Gross Profit
    		 n/a n/a n/a n/a
    Operating Income
    		 -10.17M -17.12M -15.28M -28.2M
    Interest Income
    		 351.81K 455.57K 83.99K 8.91K
    Pretax Income
    		 -23.36M -4M -15.2M -29.89M
    Net Income
    		 -23.36M -4M -15.2M -29.89M
    Selling & General & Admin
    		 5.22M 8.49M 6.22M 21.46M
    Research & Development
    		 3.44M 7.87M 9.07M 6.75M
    Other Expenses
    		 1.51M 762.83K n/a n/a
    Operating Expenses
    		 10.17M 17.12M 15.28M 28.2M
    Interest Expense
    		 n/a n/a n/a 608.46K
    Selling & Marketing Expenses
    		 439.63K 3.05M n/a 15.04M
    Cost & Expenses
    		 10.17M 17.12M 15.28M 28.2M
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 24.37K 15.43K 12.94K 11.67K
    Shares Outstanding (Diluted)
    		 24.37K 15.43K 12.94K 11.67K
    EPS (Basic)
    		 -1.11K -533 -1.17K -2.56K
    EPS (Diluted)
    		 -1.11K -533 -1.17K -2.56K
    EBITDA
    		 -23.36M -4M -15.2M -29.28M
    EBIT
    		 -23.36M -4M -15.2M -29.28M
    Depreciation & Amortization
    		 2.78M 13.12M 15.28M 18.33K

    Add to Watchlist